Pharmaceuticals: Global Industry Guide - HCPropromos.hcpro.com/pdf/BIPGIG_8786.pdf ·...

tor.com

Pharmaceuticals: Global Industry Guide

Reference Code: OHEC4958

Publication Date: April 09

BSatter

Text Box

For more information, please call Maureen Croce at 866/464-2776 Fax: 781/639-0529 email: [email protected]

TABLE OF CONTENTS

Pharmaceuticals: Global Industry Guide OHEC4958

© Datamonitor Page 4

TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION 25

1.1 What is this report about? 25

1.2 Who is the target reader? 25

1.3 How to use this report 25

1.4 Definitions 26

CHAPTER 2 GLOBAL PHARMACEUTICALS 27

2.1 Market Overview 27

2.2 Market Value 28

2.3 Market Segmentation I 29

2.4 Market Segmentation II 30

2.5 Market Share 31

2.6 Five Forces Analysis 32

2.7 Market Forecasts 40

CHAPTER 3 PHARMACEUTICALS IN ASIA-PACIFIC 41


3.2 Market Value 42



3.5 Market Share 45



BSatter

Text Box


TABLE OF CONTENTS



CHAPTER 4 PHARMACEUTICALS IN EUROPE 57


4.2 Market Value 58



4.5 Market Share 61



4.8 Macroeconomic Indicators 72

CHAPTER 5 PHARMACEUTICALS IN BELGIUM 73


5.2 Market Value 74



5.5 Market Share 77




CHAPTER 6 PHARMACEUTICALS IN CANADA 90


6.2 Market Value 91



BSatter

Text Box


TABLE OF CONTENTS



6.5 Market Share 94




CHAPTER 7 PHARMACEUTICALS IN CHINA 106


7.2 Market Value 107



7.5 Market Share 110




CHAPTER 8 PHARMACEUTICALS IN FRANCE 125









CHAPTER 9 PHARMACEUTICALS IN GERMANY 143

TABLE OF CONTENTS











CHAPTER 10 PHARMACEUTICALS IN ITALY 160









CHAPTER 11 PHARMACEUTICALS IN JAPAN 176






BSatter

Text Box


TABLE OF CONTENTS






CHAPTER 12 PHARMACEUTICALS IN THE NETHERLANDS 193









CHAPTER 13 PHARMACEUTICALS IN SPAIN 210






13.6 Five Forces analysis 215



CHAPTER 14 PHARMACEUTICALS IN THE UNITED KINGDOM 226


BSatter

Text Box


TABLE OF CONTENTS










CHAPTER 15 PHARMACEUTICALS IN THE UNITED STATES 243









CHAPTER 16 COMPANY PROFILES 259

16.1 Leading Companies 259

CHAPTER 17 APPENDIX 272

17.1 Data Research Methodology 272

BSatter

Text Box


LIST OF TABLES



LIST OF TABLES

Table 1: Global Pharmaceuticals Market Value: $ billion, 2004-2008.................................28

Table 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) .....29

Table 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) ....30

Table 4: Global Pharmaceuticals Market Share: % Share, by Value, 2008(e)....................31

Table 5: Global Pharmaceuticals Market Value Forecast: $ billion, 2008-2013..................40

Table 6: Asia-Pacific Pharmaceuticals Market Value: $ billion, 2004-2008 ........................42

Table 7: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) . .............................................................................................................................43

Table 8: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) .............................................................................................................................44

Table 9: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2008(e) ...........45

Table 10: Asia-Pacific Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 ......56

Table 11: Europe Pharmaceuticals Market Value: $ billion, 2004-2008............................58

Table 12: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e).59

Table 13: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)60

Table 14: Europe Pharmaceuticals Market Share: % Share, by Value, 2008(e) ...............61

Table 15: Europe Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 .............71

Table 16: Europe Exchange Rate, 2004-2008..................................................................72

Table 17: Belgium Pharmaceuticals Market Value: $ billion, 2004-2008...........................74

Table 18: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)75

Table 19: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) .. .........................................................................................................................76

Table 20: Belgium Pharmaceuticals Market Share: % Share, by Value, 2008(e)..............77

BSatter

Text Box


LIST OF TABLES



Table 21: Belgium Pharmaceuticals Market Value Forecast: $ billion, 2008-2013............87

Table 22: Belgium Size of Population (million) , 2004-2008..............................................88

Table 23: Belgium GDP (Constant 2000 Prices, $ billion), 2004-2008..............................88

Table 24: Belgium Inflation, 2004-2008 ............................................................................88

Table 25: Belgium Exchange Rate, 2004-2008 ................................................................89

Table 26: Canada Pharmaceuticals Market Value: $ billion, 2004-2008...........................91

Table 27: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)92

Table 28: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)... .........................................................................................................................93

Table 29: Canada Pharmaceuticals Market Share: % Share, by Value, 2008(e) ..............94

Table 30: Canada Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 ..........103

Table 31: Canada Size of Population (million) , 2004-2008 ............................................104

Table 32: Canada GDP (Constant 2000 Prices, $ billion), 2004-2008 ............................104

Table 33: Canada Inflation, 2004-2008...........................................................................104

Table 34: Canada Exchange Rate, 2004-2008...............................................................105

Table 35: China Pharmaceuticals Market Value: $ billion, 2004-2008(e)........................107

Table 36: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e).108

Table 37: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)109

Table 38: China Pharmaceuticals Market Share: % Share, by Value, 2008(e) ...............110

Table 39: China Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 .............122

Table 40: China Size of Population (million) , 2004-2008(e) ...........................................123

Table 41: China GDP (Constant 2000 Prices, $ billion), 2004-2008(e) ...........................123

Table 42: China Inflation, 2004-2008(e) .........................................................................123

BSatter

Text Box


LIST OF TABLES



Table 43: China Exchange Rate, 2004-2008(e)..............................................................124

Table 44: France Pharmaceuticals Market Value: $ billion, 2004-2008 ..........................126

Table 45: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) ..... .......................................................................................................................127

Table 46: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) .... .......................................................................................................................128

Table 47: France Pharmaceuticals Market Share: % Share, by Value, 2008(e) .............129

Table 48: France Pharmaceuticals Market Value Forecast: $ billion, 2008-2013............140

Table 49: France Size of Population (million) , 2004-2008 .............................................141

Table 50: France GDP (Constant 2000 Prices, $ billion), 2004-2008 .............................141

Table 51: France Inflation, 2004-2008 ............................................................................141

Table 52: France Exchange Rate, 2004-2008 ................................................................142

Table 53: Germany Pharmaceuticals Market Value: $ billion, 2004-2008.......................144

Table 54: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) . .......................................................................................................................145

Table 55: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) .......................................................................................................................146

Table 56: Germany Pharmaceuticals Market Share: % Share, by Value, 2008(e)..........147

Table 57: Germany Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 ........157

Table 58: Germany Size of Population (million) , 2004-2008..........................................158

Table 59: Germany GDP (Constant 2000 Prices, $ billion), 2004-2008..........................158

Table 60: Germany Inflation, 2004-2008 ........................................................................158

Table 61: Germany Exchange Rate, 2004-2008.............................................................159

Table 62: Italy Pharmaceuticals Market Value: $ billion, 2004-2008...............................161

Table 63: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) ...162

BSatter

Text Box


LIST OF TABLES



Table 64: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) ..163

Table 65: Italy Pharmaceuticals Market Share: % Share, by Value, 2008(e)..................164

Table 66: Italy Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 ................173

Table 67: Italy Size of Population (million) , 2004-2008 ..................................................174

Table 68: Italy GDP (Constant 2000 Prices, $ billion), 2004-2008 ..................................174

Table 69: Italy Inflation, 2004-2008.................................................................................174

Table 70: Italy Exchange Rate, 2004-2008.....................................................................175

Table 71: Japan Pharmaceuticals Market Value: $ billion, 2004-2008............................177

Table 72: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 178

Table 73: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)179

Table 74: Japan Pharmaceuticals Market Share: % Share, by Value, 2008(e)...............180

Table 75: Japan Pharmaceuticals Market Value Forecast: $ billion, 2008-2013.............190

Table 76: Japan Size of Population (million) , 2004-2008...............................................191

Table 77: Japan GDP (Constant 2000 Prices, $ billion), 2004-2008...............................191

Table 78: Japan Inflation, 2004-2008 .............................................................................191

Table 79: Japan Exchange Rate, 2004-2008..................................................................192

Table 80: Netherlands Pharmaceuticals Market Value: $ million, 2004-2008 .................194

Table 81: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) .......................................................................................................................195

Table 82: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) .......................................................................................................................196

Table 83: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2008(e) .....197

Table 84: Netherlands Pharmaceuticals Market Value Forecast: $ million, 2008-2013 ..207

Table 85: Netherlands Size of Population (million) , 2004-2008 .....................................208

BSatter

Text Box


LIST OF TABLES



Table 86: Netherlands GDP (Constant 2000 Prices, $ billion), 2004-2008 .....................208

Table 87: Netherlands Inflation, 2004-2008....................................................................208

Table 88: Netherlands Exchange Rate, 2004-2008 ........................................................209

Table 89: Spain Pharmaceuticals Market Value: $ billion, 2004-2008 ............................211

Table 90: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) .212

Table 91: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 213

Table 92: Spain Pharmaceuticals Market Share: % Share, by Value, 2008(e) ...............214

Table 93: Spain Pharmaceuticals Market Value Forecast: $ billion, 2008-2013..............223

Table 94: Spain Size of Population (million) , 2004-2008 ...............................................224

Table 95: Spain GDP (Constant 2000 Prices, $ billion), 2004-2008 ...............................224

Table 96: Spain Inflation, 2004-2008 ..............................................................................224

Table 97: Spain Exchange Rate, 2004-2008 ..................................................................225

Table 98: United Kingdom Pharmaceuticals Market Value: $ billion, 2004-2008 ............227

Table 99: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) .......................................................................................................................228

Table 100: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) .......................................................................................................................229

Table 101: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2008(e)230

Table 102: United Kingdom Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 ... .......................................................................................................................240

Table 103: United Kingdom Size of Population (million) , 2004-2008 ...............................241

Table 104: United Kingdom GDP (Constant 2000 Prices, $ billion), 2004-2008 ...............241

Table 105: United Kingdom Inflation, 2004-2008..............................................................241

Table 106: United Kingdom Exchange Rate, 2004-2008 ..................................................242

BSatter

Text Box


LIST OF TABLES



Table 107: United States Pharmaceuticals Market Value: $ billion, 2004-2008 ................244

Table 108: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) .......................................................................................................................245

Table 109: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) .......................................................................................................................246

Table 110: United States Pharmaceuticals Market Share: % Share, by Value, 2008(e) ...247

Table 111: United States Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 .257

Table 112: United States Size of Population (million) , 2004-2008 ...................................258

Table 113: United States GDP (Constant 2000 Prices, $ billion), 2004-2008 ...................258

Table 114: United States Inflation, 2004-2008..................................................................258

Table 115: Key Facts: Pfizer Inc.......................................................................................259

Table 116: Key Financials: Pfizer Inc................................................................................261

Table 117: Key Facts: GlaxoSmithKline Plc .....................................................................262

Table 118: Key Financials: GlaxoSmithKline Plc ..............................................................265

Table 119: Key Facts: Merck & Co., Inc. ..........................................................................266

Table 120: Key Financials: Merck & Co., Inc. ...................................................................268

Table 121: Key Facts: AstraZeneca PLC..........................................................................269

Table 122: Key Financials: AstraZeneca PLC ..................................................................271

BSatter

Text Box


LIST OF FIGURES



LIST OF FIGURES

Figure 1: Global Pharmaceuticals Market Value: $ billion, 2004-2008 .............................28

Figure 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)..29

Figure 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e).30

Figure 4: Global Pharmaceuticals Market Share: % Share, by Value, 2008(e) ................31

Figure 5: Forces Driving Competition in the Global Pharmaceuticals Market...................32

Figure 6: Drivers of Buyer Power in the Global Pharmaceuticals Market .........................33

Figure 7: Drivers of Supplier Power in the Global Pharmaceuticals Market .....................34

Figure 8: Factors Influencing the Likelihood of New Entrants in the Global Pharmaceuticals Market..................................................................................................36

Figure 9: Factors Influencing the Threat of Substitutes in the Global Pharmaceuticals Market .........................................................................................................................38

Figure 10: Drivers of Degree of Rivalry in the Global Pharmaceuticals Market ..................39

Figure 11: Global Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 ..............40

Figure 12: Asia-Pacific Pharmaceuticals Market Value: $ billion, 2004-2008.....................42

Figure 13: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) .........................................................................................................................43

Figure 14: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) .........................................................................................................................44

Figure 15: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2008(e)........45

Figure 16: Forces Driving Competition in the Asia-Pacific Pharmaceuticals Market ..........46

Figure 17: Drivers of Buyer Power in the Asia-Pacific Pharmaceuticals Market.................48

Figure 18: Drivers of Supplier Power in the Asia-Pacific Pharmaceuticals Market .............50

Figure 19: Factors Influencing the Likelihood of New Entrants in the Asia-Pacific Pharmaceuticals Market..................................................................................................52

BSatter

Text Box


LIST OF FIGURES



Figure 20: Factors Influencing the Threat of Substitutes in the Asia-Pacific Pharmaceuticals Market..................................................................................................54

Figure 21: Drivers of Degree of Rivalry in the Asia-Pacific Pharmaceuticals Market..........55

Figure 22: Asia-Pacific Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 ......56

Figure 23: Europe Pharmaceuticals Market Value: $ billion, 2004-2008............................58

Figure 24: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e).59

Figure 25: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)60

Figure 26: Europe Pharmaceuticals Market Share: % Share, by Value, 2008(e) ...............61

Figure 27: Forces Driving Competition in the Pharmaceuticals Market in Europe..............62

Figure 28: Drivers of Buyer Power in the Pharmaceuticals Market in Europe ....................64

Figure 29: Drivers of Supplier Power in the Pharmaceuticals Market in Europe ................65

Figure 30: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Europe.............................................................................................................67

Figure 31: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Europe .........................................................................................................................69

Figure 32: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Europe .............70

Figure 33: Europe Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 .............71

Figure 34: Belgium Pharmaceuticals Market Value: $ billion, 2004-2008...........................74

Figure 35: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)75

Figure 36: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) .. .........................................................................................................................76

Figure 37: Belgium Pharmaceuticals Market Share: % Share, by Value, 2008(e)..............77

Figure 38: Forces Driving Competition in the Pharmaceuticals Market in Belgium ............78

Figure 39: Drivers of Buyer Power in the Pharmaceuticals Market in Belgium...................80

Figure 40: Drivers of Supplier Power in the Pharmaceuticals Market in Belgium...............81

BSatter

Text Box


LIST OF FIGURES



Figure 41: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Belgium ...........................................................................................................83

Figure 42: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Belgium .........................................................................................................................85

Figure 43: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Belgium............86

Figure 44: Belgium Pharmaceuticals Market Value Forecast: $ billion, 2008-2013............87

Figure 45: Canada Pharmaceuticals Market Value: $ billion, 2004-2008...........................91

Figure 46: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)92

Figure 47: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)... .........................................................................................................................93

Figure 48: Canada Pharmaceuticals Market Share: % Share, by Value, 2008(e) ..............94

Figure 49: Forces Driving Competition in the Pharmaceuticals Market in Canada.............95

Figure 50: Drivers of Buyer Power in the Pharmaceuticals Market in Canada ...................97

Figure 51: Drivers of Supplier Power in the Pharmaceuticals Market in Canada ...............98

Figure 52: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Canada............................................................................................................99

Figure 53: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Canada .......................................................................................................................101

Figure 54: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Canada ..........102

Figure 55: Canada Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 ..........103

Figure 56: China Pharmaceuticals Market Value: $ billion, 2004-2008(e)........................107

Figure 57: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e).108

Figure 58: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)109

Figure 59: China Pharmaceuticals Market Share: % Share, by Value, 2008(e) ...............110

Figure 60: Forces Driving Competition in the Pharmaceuticals Market in China..............111

BSatter

Text Box


LIST OF FIGURES



Figure 61: Drivers of Buyer Power in the Pharmaceuticals Market in China ....................113

Figure 62: Drivers of Supplier Power in the Pharmaceuticals Market in China ................115

Figure 63: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in China.............................................................................................................117

Figure 64: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in China .......................................................................................................................119

Figure 65: Drivers of Degree of Rivalry in the Pharmaceuticals Market in China .............120

Figure 66: China Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 .............122

Figure 67: France Pharmaceuticals Market Value: $ billion, 2004-2008 ..........................126

Figure 68: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) ..... .......................................................................................................................127

Figure 69: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) .... .......................................................................................................................128

Figure 70: France Pharmaceuticals Market Share: % Share, by Value, 2008(e) .............129

Figure 71: Forces Driving Competition in the Pharmaceuticals Market in France ............130

Figure 72: Drivers of Buyer Power in the Pharmaceuticals Market in France ..................132

Figure 73: Drivers of Supplier Power in the Pharmaceuticals Market in France...............134

Figure 74: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in France...........................................................................................................136

Figure 75: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in France .......................................................................................................................138

Figure 76: Drivers of Degree of Rivalry in the Pharmaceuticals Market in France ...........139

Figure 77: France Pharmaceuticals Market Value Forecast: $ billion, 2008-2013............140

Figure 78: Germany Pharmaceuticals Market Value: $ billion, 2004-2008.......................144

Figure 79: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) . .......................................................................................................................145

BSatter

Text Box


LIST OF FIGURES



Figure 80: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) .......................................................................................................................146

Figure 81: Germany Pharmaceuticals Market Share: % Share, by Value, 2008(e)..........147

Figure 82: Forces Driving Competition in the Pharmaceuticals market in Germany.........148

Figure 83: Drivers of Buyer Power in the Pharmaceuticals market in Germany...............150

Figure 84: Drivers of Supplier Power in the Pharmaceuticals market in Germany ...........151

Figure 85: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals market in Germany .......................................................................................................153

Figure 86: Factors Influencing the Threat of Substitutes in the Pharmaceuticals market in Germany ....................................................................................................................155

Figure 87: Drivers of Degree of Rivalry in the Pharmaceuticals market in Germany........156

Figure 88: Germany Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 ........157

Figure 89: Italy Pharmaceuticals Market Value: $ billion, 2004-2008...............................161

Figure 90: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) ...162

Figure 91: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) ..163

Figure 92: Italy Pharmaceuticals Market Share: % Share, by Value, 2008(e)..................164

Figure 93: Forces Driving Competition in the Pharmaceuticals Market in Italy.................165

Figure 94: Drivers of Buyer Power in the Pharmaceuticals Market in Italy .......................166

Figure 95: Drivers of Supplier Power in the Pharmaceuticals Market in Italy ...................167

Figure 96: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Italy ...............................................................................................................169

Figure 97: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Italy .......................................................................................................................171

Figure 98: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Italy ................172

Figure 99: Italy Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 ................173

BSatter

Text Box


LIST OF FIGURES



Figure 100: Japan Pharmaceuticals Market Value: $ billion, 2004-2008 ........................177

Figure 101: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)... ....................................................................................................................178

Figure 102: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e).. ....................................................................................................................179

Figure 103: Japan Pharmaceuticals Market Share: % Share, by Value, 2008(e) ...........180

Figure 104: Forces Driving Competition in the Pharmaceuticals Market in Japan ..........181

Figure 105: Drivers of Buyer Power in the Pharmaceuticals Market in Japan ................183

Figure 106: Drivers of Supplier Power in the Pharmaceuticals Market in Japan.............184

Figure 107: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Japan ............................................................................................................186

Figure 108: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Japan ....................................................................................................................188

Figure 109: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Japan .........189

Figure 110: Japan Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 .........190

Figure 111: Netherlands Pharmaceuticals Market Value: $ million, 2004-2008..............194

Figure 112: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) ....................................................................................................................195

Figure 113: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) ....................................................................................................................196

Figure 114: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2008(e)..197

Figure 115: Forces Driving Competition in the Pharmaceuticals Market in the Netherlands. ....................................................................................................................198

Figure 116: Drivers of Buyer Power in the Pharmaceuticals Market in the Netherlands.200

Figure 117: Drivers of Supplier Power in the Pharmaceuticals Market in the Netherlands ... ....................................................................................................................201

BSatter

Text Box


LIST OF FIGURES



Figure 118: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the Netherlands .............................................................................................203

Figure 119: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the Netherlands.............................................................................................................205

Figure 120: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the Netherlands ....................................................................................................................206

Figure 121: Netherlands Pharmaceuticals Market Value Forecast: $ million, 2008-2013..... ....................................................................................................................207

Figure 122: Spain Pharmaceuticals Market Value: $ billion, 2004-2008.........................211

Figure 123: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) ... ....................................................................................................................212

Figure 124: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) .. ....................................................................................................................213

Figure 125: Spain Pharmaceuticals Market Share: % Share, by Value, 2008(e)............214

Figure 126: Forces Driving Competition in the Pharmaceuticals market in Spain...........215

Figure 127: Drivers of Buyer Power in the Pharmaceuticals market in Spain.................217

Figure 128: Drivers of Supplier Power in the Pharmaceuticals market in Spain .............218

Figure 129: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals market in Spain.............................................................................................................219

Figure 130: Factors Influencing the Threat of Substitutes in the Pharmaceuticals market in Spain ....................................................................................................................221

Figure 131: Drivers of Degree of Rivalry in the Pharmaceuticals market in Spain..........222

Figure 132: Spain Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 ..........223

Figure 133: United Kingdom Pharmaceuticals Market Value: $ billion, 2004-2008.........227

Figure 134: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) ....................................................................................................................228

Figure 135: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) ....................................................................................................................229

BSatter

Text Box


LIST OF FIGURES



Figure 136: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2008(e).. ....................................................................................................................230

Figure 137: Forces Driving Competition in the Pharmaceuticals Market in the UK.........231

Figure 138: Drivers of Buyer Power in the Pharmaceuticals Market in the UK ...............233

Figure 139: Drivers of Supplier Power in the Pharmaceuticals Market in the UK ...........235

Figure 140: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the UK ...........................................................................................................237

Figure 141: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the UK ....................................................................................................................238

Figure 142: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the UK ........239

Figure 143: United Kingdom Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 ....................................................................................................................240

Figure 144: United States Pharmaceuticals Market Value: $ billion, 2004-2008.............244

Figure 145: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) ....................................................................................................................245

Figure 146: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) ....................................................................................................................246

Figure 147: United States Pharmaceuticals Market Share: % Share, by Value, 2008(e)247

Figure 148: Forces Driving Competition in the Pharmaceutical Market in the US...........248

Figure 149: Drivers of Buyer Power in the Pharmaceutical Market in the US.................250

Figure 150: Drivers of Supplier Power in the Pharmaceutical Market in the US .............251

Figure 151: Factors Influencing the Likelihood of New Entrants in the Pharmaceutical Market in the US ...........................................................................................................253

Figure 152: Factors Influencing the Threat of Substitutes in the Pharmaceutical Market in the US ....................................................................................................................255

Figure 153: Drivers of Degree of Rivalry in the Pharmaceutical Market in the US..........256

BSatter

Text Box


LIST OF FIGURES



Figure 154: United States Pharmaceuticals Market Value Forecast: $ billion, 2008-2013.... ....................................................................................................................257

Figure 155: Revenues & Profitability: Pfizer Inc .............................................................261

Figure 156: Revenues & Profitability: GlaxoSmithKline Plc ............................................265

Figure 157: Revenues & Profitability: Merck & Co., Inc. .................................................268

Figure 158: Revenues & Profitability: AstraZeneca PLC ................................................271

BSatter

Text Box


INTRODUCTION



CHAPTER 1 INTRODUCTION

This report contains easily comparable data on market value, volume, segmentation and market share for the Global Pharmaceuticals market, plus full five-year market forecasts. It examines future problems, innovations and potential growth areas within the market.

1.1 What is this report about?

This report is a part of Datamonitor’s Global Industry Guide series, which includes comprehensive category data and analysis across all major industry sectors. These incisive reports include key data points, charts and expert analysis on a global, regional and country basis.

1.2 Who is the target reader?

This report should make essential reading for anyone involved in the Pharmaceuticals market globally - plus anyone considering expansion into Pharmaceuticals market, or targeting customers or suppliers in the market.

This report should be read by competitive analysts, distribution managers, marketing managers, strategic planners and senior executives.

1.3 How to use this report

This introductory section sets out the report style and explains the definitions used in following chapters; chapter two is a global overview of the industry; chapters 3 to 15 consider different country and regional markets and chapter 17 is an appendix that details Datamonitor’s research methodology.

BSatter

Text Box


INTRODUCTION



1.4 Definitions

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2007 annual average exchange rates.

The global figure comprises the Americas, Asia-Pacific and Europe.

BSatter

Text Box


PHARMACEUTICALS IN ASIA-PACIFIC



3.5 Market Share

Takeda Pharmaceutical Company Ltd. is a leading company in Asia-Pacific pharmaceuticals market with 4.8% of the market’s value.

Astellas Pharma holds further 4.3% of the Asia-Pacific pharmaceuticals market’s share.

Table 9: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Company % Share Takeda Pharmaceutical Company Limited 4.80%Astellas Pharma 4.30%Pfizer Inc 4.00%Daiichi Sankyo Co., Ltd. 3.00%Other 84.00% Total 100.0% Source: Datamonitor D A T A M O N I T O R

Figure 15: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Source: Datamonitor D A T A M O N I T O R

Takeda Pharmaceutical

Company Limited4.8%

Astellas Pharma4.3%

Pf izer Inc4.0%

Daiichi Sankyo Co., Ltd.

3.0%

Other84.0%

BSatter

Text Box


PHARMACEUTICALS IN GERMANY



9.3 Market Segmentation I

The sale of Central Nervous System pharmaceuticals accounts for 19.8% of the European pharmaceuticals market.

In comparison, sale of Cardiovascular pharmaceuticals accounts for further 18.6% of the market’s revenue.

Table 54: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Category % Share Other therapeutic purposes 39.90%Central Nervous System 17.40%Cardiovascular 13.20%Alimentary/Metabolism 12.40%Anti-Infectives 9.80%Respiratory 7.30% Total 100.0% Source: Datamonitor D A T A M O N I T O R

Figure 79: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Source: Datamonitor D A T A M O N I T O R

Other therapeutic purposes

39.9%

Cardiovascular13.2%

Alimentary/Metabolism

12.4%

Anti-Infectives9.8%

Respiratory7.3%

Central Nervous System17.4%

BSatter

Text Box


PHARMACEUTICALS IN THE UNITED KINGDOM



14.6 Five Forces Analysis

Summary Figure 137: Forces Driving Competition in the Pharmaceuticals Market in

the UK

012345

Buyer Pow er

Supplier Pow er

New EntrantsSubstitutes

Degree of rivalry

Score for each force is mean of scores for its drivers. Total area & color indicates intensity of competition overall. Source: Datamonitor D A T A M O N I T O R

The UK pharmaceutical market will be analysed taking the end-users, individuals as well as institutions like hospitals, clinics or any other private or national health services as buyers, pharmaceutical companies as players and providers of the production devices of all kinds as suppliers. Pharmaceutical market is one of the most beneficial markets in Europe. The sum earmarked for investment in research and new technology solutions in this market ranks second in terms of volume, after the automotive industry. However the UK decreasing, pharmaceutical market is becoming less attractive for players compared with the US or Asia-Pacific market.

Intensity of competition

Weak Strong

BSatter

Text Box


PHARMACEUTICALS IN THE UNITED STATES



Supplier Power Figure 150: Drivers of Supplier Power in the Pharmaceutical Market in the

US

012345

Supplier size

Oligopoly threat

Sw itching costs

Player independence

Player dispensabilityNo substitute inputs

Importance of quality/cost

Differentiated input

Forw ard integration

Scores: 1= weak driver...5=strong driver Source: Datamonitor D A T A M O N I T O R

Major suppliers to the pharmaceutical industry are manufacturers of Active Pharmaceutical Ingredients (API), forming the sub section of the chemical industry. Most large multinational pharmaceutical companies have major investments in fine chemical manufacturing, providing them a degree of self-sufficiency. However, the wide diversity of chemicals required by pharmaceutical companies means that manufacturers of APIs maintain supplier power.

Although it is less likely that suppliers of APIs would forward integrate into the pharmaceutical industry with respect to the development and marketing of new branded drugs, their capabilities in chemical synthesis make them ideal candidates for forward integration into the manufacture of generic drugs. Furthermore, many leading pharmaceutical companies have divested some of their chemical synthesis operations in a bid to enhance profitability in recent years.

Strength of supplier power

Weak Strong

BSatter

Text Box


Pharmaceuticals: Global Industry Guide - HCPropromos.hcpro.com/pdf/BIPGIG_8786.pdf ·...

Documents

Transcript of Pharmaceuticals: Global Industry Guide - HCPropromos.hcpro.com/pdf/BIPGIG_8786.pdf ·...